4-Year Update of the Echelon-1 Study #ASH19 #ASH @TakedaOncology

4-Year Update of the Echelon-1 Study #ASH19 #ASH @TakedaOncology

ash

2 months
27 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:

Thanos Zomas, MD of @TakedaOncology discusses brentuximab vedotin with chemotherapy for stage 3/4 classical hodgkin lymphoma (cHL): 4-year update of the echelon-1 study.

Up Next Autoplay